*** Welcome to piglix ***

Bromantane

Bromantane
Bromantane structure.svg
Bromantane ball-and-stick model.png
Clinical data
Routes of
administration
Oral (tablets)
ATC code
  • None
Legal status
Legal status
  • US: Unscheduled not FDA approved
  • ℞-only (RU)
Pharmacokinetic data
Bioavailability 42%
Biological half-life 11,21 hours (in humans),
7 hours (in rats)
Identifiers
Synonyms Bromantan; Bromontan;
Ladasten; ADK-709
CAS Number
PubChem CID
ChemSpider
ECHA InfoCard 100.213.907
Chemical and physical data
Formula C16H20BrN
Molar mass 306.246 g/mol
3D model (Jmol)
 NYesY (what is this?)  

Bromantane (brand name Ladasten, also known in Russia as adamantylbromphenylamine) is an atypical psychostimulant and anxiolytic drug of the adamantane family that is used in Russia in the treatment of neurasthenia. Although the effects of the bromantane have been determined to be dependent on the dopaminergic and possibly serotonergic neurotransmitter systems, its exact mechanism of action is unknown, and it is distinct in its properties relative to typical psychostimulants such as amphetamine. Because of its unique aspects, bromantane has sometimes been described instead as an adaptogen and actoprotector.

In the 1960s, the adamantane derivative amantadine (1-aminoadamantane) was developed as an antiviral drug for the treatment of influenza. Other adamantane antivirals subsequently followed, such as rimantadine (1-(1-aminoethyl)adamantane) and adapromine (1-(1-aminopropyl)adamantane). It was serendipitously discovered in 1969 that amantadine possesses central dopaminergic psychostimulant-like properties, and subsequent investigation revealed that rimantadine and adapromine also possess such properties. Amantadine was then developed and introduced for the treatment of Parkinson's disease due to its ability to increase dopamine levels in the brain. It has also notably since been used to help alleviate fatigue in multiple sclerosis.


...
Wikipedia

...